MedPath

Endoscopic management of patients with high risk T1a and T1b N0M0 esophageal adenocarcinoma: a prospective multicenter registry

Recruiting
Conditions
esophageal cancer
10017990
Registration Number
NL-OMON54809
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
175
Inclusion Criteria

1. Patients with high risk mucosal or submucosal EAC diagnosed in an ER
specimen, diagnosed by an expert gastrointestinal (GI) pathologist.
2. Signed informed consent.

Exclusion Criteria

1. Prior history of esophageal cancer (invasion of T1sm or deeper or HR T1a).
2. Synchronous esophageal squamous cell carcinoma
3. Suspicion on lymph node metastasis or distant metastasis on EUS, ultrasound
of the neck, CT-thorax-abdomen or PET-CT during baseline measurement.
4. Tumor-positive deep resection margin (R1) in ER/ESD specimen
5. Patients unable to give signed informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1.5-year disease-specific mortality/survival<br /><br>2.Overall survival</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Lymph node metastasis, confirmed by cytology and and/or histology .<br /><br>2. Local recurrence eligible for endoscopic therapy<br /><br>3. Local recurrence requiring surgical therapy<br /><br>4. Distant metastasis, histopathologically and/or cytologically proven.<br /><br>5. Quality of life</p><br>
© Copyright 2025. All Rights Reserved by MedPath